MORRISVILLE, N.C., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Syneos Health (SYNH) ® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced the launch of a ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Please replace the release dated Jan. 28, 2025 with the following corrected version due to multiple revisions. The updated release ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., a leading provider of clinical development technology, today announced new data from the Tufts Center for the Study of Drug Development (CSDD)’s PACT ...
In this interview, Eric Klaver, the DCT regulatory director for decentralized clinical trials at IQVIA, aiding in compliance of the DCT strategy and platform, shares how IQVIA supports investigators ...
Characterizing vaginal stenosis in female cancer survivors. The feasibility and preliminary efficacy of a locally developed digital health intervention in improving breast cancer survivor’s quality of ...
Time toxicity in early-phase clinical trials. This is an ASCO Meeting Abstract from the 2023 ASCO Quality Care Symposium. This abstract does not include a full text component.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results